-
Worth Watching Stocks: CenturyLink (NYSE:CTL), TRACON Pharmaceuticals (NASDAQ:TCON), Summit Financial Group Inc. (NASDAQ:SMMF), Rubicon Technology (NASDAQ:RBCN), Enzon Pharmaceuticals (NASDAQ:ENZN)
On Tuesday shares of CenturyLink, Inc. (NYSE:CTL) closed at $35.13. Company’s sales growth for last 5 years was 29.40% and EPS growth for next 5 years is recorded as 0.10%. CenturyLink, Inc. (NYSE:CTL) announced the availability of CenturyLink Cloud in Asia Pacific. The public cloud platform – available in the United States, United Kingdom, Canada…
-
Top News: Keryx Biopharmaceuticals (NASDAQ:KERX), MER Telemanagement Solutions (NASDAQ:MTSL), E. I. du Pont de Nemours NYSE:DD), Enzon Pharmaceuticals (NASDAQ:ENZN), Brocade Communications (NASDAQ:BRCD)
Investment analysts at Mizuho lowered their price objective on shares of Keryx Biopharmaceuticals (NASDAQ:KERX) from $30.00 to $25.00 in a note issued to investors on Tuesday. The firm currently has a “buy” rating on the stock. Mizuho’s target price suggests a potential upside of 107.81% from the company’s current price. On Friday shares of Keryx…
-
Notable Stocks in Focus: Penn National Gaming Inc. (NASDAQ:PENN), Advanced Micro Devices (NASDAQ:AMD), The Advisory Board (NASDAQ:ABCO), UFP Technologies (NASDAQ:UFPT), Enzon Pharmaceuticals (NASDAQ:ENZN)
Penn National Gaming, Inc. (PENN:Nasdaq) announced that it will release its 2014 fourth quarter financial results at 7:00 a.m. ET on Thursday, January 29, 2015 and will host a conference call and simultaneous webcast at 10:00 a.m. ET on Thursday, January 29, 2015. On Wednesday shares of Penn National Gaming Inc. (NASDAQ:PENN) closed at $15.42.…
-
Top Biotech Decliners: Infinity Pharmaceuticals (NASDAQ:INFI), Stemline Therapeutics (NASDAQ:STML), Brainstorm Cell Therapeutics (NASDAQ:BCLI), Dicerna Pharmaceuticals (NASDAQ:DRNA), Enzon Pharmaceuticals Inc. (NASDAQ:ENZN)
Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) said Thursday that it will stop any further clinical development of its experimental drug duvelisib for the treatment of rheumatoid arthritis, as a mid-stage study evaluating the drug for that purpose failed to meet its main goal. On Thursday shares of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) closed at $14.34. Company’s EPS growth…
-
Don’t Miss These Stocks: GoPro (NASDAQ:GPRO), Eldorado Gold Corporation (NYSE:EGO), Appliance Recycling Centers (NASDAQ:ARCI), Enzon Pharmaceuticals (NASDAQ:ENZN), Kosmos Energy (NYSE:KOS)
Pacific Crest reiterated their hold rating on shares of GoPro Inc. (NASDAQ:GPRO) in a research report released on Tuesday morning. GoPro, Inc. (NASDAQ:GPRO) in last trading activity increased 5.77% to close at $66.87. Company weekly performance is 0.69% while its quarterly performance stands at -21.75%. GoPro, Inc. (NASDAQ:GPRO) is -32.09% away from its 52 week…
-
Market Watch: Enzon Pharmaceuticals Inc. (NASDAQ:ENZN), Celladon Corporation (NASDAQ:CLDN), Ashford Hospitality Prime (NYSE:AHP), TransDigm Group Incorporated (NYSE:TDG), MSCI Inc. (NYSE:MSCI)
Enzon Pharmaceuticals Inc (NASDAQ:ENZN) declared a special dividend on Tuesday, December 9th, Analyst Ratings Netreports. Stockholders of record on Monday, January 12th will be given a dividend of 0.10 per share on Wednesday, January 28th. The ex-dividend date of this dividend is Thursday, January 8th. Enzon Pharmaceuticals Inc. (NASDAQ:ENZN) in last trading activity advanced 0.98%…
-
Must Watch These 5 Stocks: EP Energy Corporation (NYSE:EPE), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), TransCanada Corp. (NYSE:TRP), LGI Homes (NASDAQ:LGIH), Enzon Pharmaceuticals (NASDAQ:ENZN)
Wells Fargo & Co. restated their hold rating on shares of EP Energy Corp (NYSE:EPE) in a report released on Thursday. EP Energy Corporation (NYSE:EPE) in last trading activity advanced 9.07% to close at $10.94. Company weekly performance is 44.90% while its quarterly performance stands at -36.98%. EP Energy Corporation (NYSE:EPE) is -52.91% away from…
-
Investors Should Watch: Bank of America Corporation (NYSE:BAC), Halliburton Company (NYSE:HAL), Enzon Pharmaceuticals Inc. (NASDAQ:ENZN), Cleveland BioLabs (NASDAQ:CBLI), Hemispherx Biopharma (NYSEMKT:HEB)
Bank of America Corporation (NYSE:BAC) announced the Board of Directors authorized a regular quarterly cash dividend of $18.125 per share on the 7.25 percent Non-Cumulative Perpetual Convertible Preferred Stock, Series L. The dividend is payable on January 30, 2015 to shareholders of record as of January 1, 2015. Bank of America Corporation (NYSE:BAC) in last…
-
Stock in News: AT&T (NYSE:T), Yahoo! Inc. (NASDAQ:YHOO), Covanta Holding Corporation (NYSE:CVA), Asia Pacific Wire & Cable (NASDAQ:APWC), Enzon Pharmaceuticals (NASDAQ:ENZN)
AT&T Inc. (NYSE:T) has no reason to hurry into any more deals in Mexico. In fact, the more patiently the U.S. phone company waits, the better. AT&T has made two acquisitions this year in its expansion into Mexico — neither with billionaire Carlos Slim, who dominates the country’s communications industry. Instead, AT&T has committed more…
-
Morning Buzz: Akamai Technologies (NASDAQ:AKAM), Enzon Pharmaceuticals Inc. (NASDAQ:ENZN), Crown Media (NASDAQ:CRWN), Universal Security Instruments Inc. (NYSEMKT:UUU), Global Power Equipment (NYSE:GLPW)
Akamai Technologies (NASDAQ:AKAM) Director George H. Conrades unloaded 22,340 shares of Akamai Technologies stock on the open market in a transaction dated Wednesday, November 26th. The shares were sold at an average price of $64.14, for a total transaction of $1,432,887.60. Akamai Technologies, Inc. (NASDAQ:AKAM) in last trading activity increased 1.57% to close at $64.23.…